Activated H-Ras regulates hematopoietic cell survived by modulating Survivin

被引:19
作者
Fukuda, S [1 ]
Pelus, LM [1 ]
机构
[1] Indiana Univ, Sch Med, Walther Oncol Ctr, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
关键词
Survivin; Ras; leukemia; apoptosis; cell cycle;
D O I
10.1016/j.bbrc.2004.08.149
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survivin expression and Ras activation are regulated by hematopoietic growth factors. We investigated whether activated Ras could circumvent growth factor-regulated Survivin expression and if a Ras/Survivin axis mediates growth factor independent survival and proliferation in hematopoietic cells. Survivin expression is up-regulated by IL-3 in Ba/F3 and CD34(+) cells and inhibited by the Ras inhibitor, farnesylthiosalicylic acid. Over-expression of constitutively activated H-Ras (CA-Ras) in Ba/F3 cells blocked down-modulation of Survivin expression, G(0)/G(1) arrest, and apoptosis induced by IL-3 withdrawal, while dominant-negative (DN) H-Ras down-regulated Survivin. Survivin disruption by DN T34A Survivin blocked CA-Ras-induced IL-3-independent cell survival and proliferation; however, it did not affect CA-Ras-mediated enhancement of S-phase, indicating that the anti-apoptotic activity of CA-Ras is Survivin dependent while its S-phase enhancing effect is not. These results indicate that CA-Ras modulates Survivin expression independent of hematopoietic growth factors and that a CA-Ras/Survivin axis regulates survival and proliferation of transformed hematopoietic cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:636 / 644
页数:9
相关论文
共 45 条
  • [1] Expression and prognostic significance of survivin in de novo acute myeloid leukaemia
    Adida, C
    Recher, C
    Raffoux, E
    Daniel, MT
    Taksin, AL
    Rousselot, P
    Sigaux, F
    Degos, L
    Altieri, DC
    Dombret, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) : 196 - 203
  • [2] Validating survivin as a cancer therapeutic target
    Altieri, DC
    [J]. NATURE REVIEWS CANCER, 2003, 3 (01) : 46 - 54
  • [3] Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma
    Aoki, Y
    Feldman, GM
    Tosato, G
    [J]. BLOOD, 2003, 101 (04) : 1535 - 1542
  • [4] Badran A, 2003, INT J ONCOL, V22, P59
  • [5] RAS and leukemia:: From basic mechanisms to gene-directed therapy
    Beaupre, DM
    Kurzrock, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 1071 - 1079
  • [6] Signal transducer and activator of transcription proteins in leukemias
    Benekli, M
    Baer, MR
    Baumann, H
    Wetzler, M
    [J]. BLOOD, 2003, 101 (08) : 2940 - 2954
  • [7] BOS JL, 1989, CANCER RES, V49, P4682
  • [8] Cytokine-regulated expression of survivin in myeloid leukemia
    Carter, BZ
    Milella, M
    Altieri, DC
    Andreeff, M
    [J]. BLOOD, 2001, 97 (09) : 2784 - 2790
  • [9] Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions
    Conway, EM
    Pollefeyt, S
    Cornelissen, J
    DeBaere, I
    Steiner-Mosonyi, M
    Ong, K
    Baens, M
    Collen, D
    Schuh, AC
    [J]. BLOOD, 2000, 95 (04) : 1435 - 1442
  • [10] Ras proteins in the control of the cell cycle and cell differentiation
    Crespo, P
    León, J
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (11) : 1613 - 1636